학술논문

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
Document Type
Article
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, May 2023, 23(5):578-588)
Subject
Language
English
ISSN
14744457
14733099